우정바이오: insider trades · South Korea · DART (FSS)

Discover the full directors' dealings record of 우정바이오, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 우정바이오 has published 16 insider filings. Market capitalisation: €46.7bn. The latest transaction was reported on 3 April 2026 (Other). Among the most active insiders: 수성자산운용. Every trade is openly available.